文献速递中毒与环境急症重症综合管理与镇静镇痛

既往一氧化碳中毒的死亡风险与死因:一项全国性人群队列研究

Mortality Risks and Causes in Previous Carbon Monoxide Poisoning: A Nationwide Population-Based Cohort Study.
PubMed 文献 · Crit Care Med · 2024-09-18
一句话结论基于韩国全国数据库的匹配队列显示,既往一氧化碳中毒者全因死亡风险显著高于对照(aHR 15.67),外因死亡(含自杀)风险最高(aHR 50.07)。

该研究利用韩国国民健康保险服务数据库与国家死亡登记库,纳入2002—2020年确诊一氧化碳中毒的成人患者,并按年龄、性别、保险类型、收入水平、居住地、吸烟、饮酒、肥胖状态、内外科及精神疾病史和Charlson合并症指数1:1匹配对照,随访至2022年或死亡/移民。共纳入48,600例一氧化碳中毒患者及匹配对照,女性占41.30%,平均年龄48.05岁。一氧化碳中毒组全因死亡风险显著升高(aHR 15.67,95%CI 12.58-19.51),感染、肿瘤、内分泌、神经、心血管、呼吸、消化系统疾病及外因(含自杀)死亡风险均显著高于对照。提示急诊/ICU对一氧化碳中毒患者出院后需关注远期多系统死亡风险及自杀风险。

要点

  • 一氧化碳中毒组全因死亡风险显著高于匹配对照:aHR 15.67(95%CI 12.58-19.51)。
  • 外因死亡(包括自杀)风险最高:aHR 50.07(95%CI 30.98-80.90)。
  • 消化系统疾病死亡aHR 24.72(95%CI 3.34-182.69),呼吸系统疾病死亡aHR 17.54(95%CI 5.48-56.17)。
  • 内分泌疾病死亡aHR 13.44(95%CI 1.76-102.70),心血管疾病死亡aHR 8.97(95%CI 5.05-15.93)。
  • 神经疾病死亡aHR 7.42(95%CI 2.91-18.90),感染死亡aHR 6.71(95%CI 1.51-29.72),肿瘤死亡aHR 5.20(95%CI 3.39-7.99)。

适用人群与场景

  • 2002—2020年韩国国民健康保险服务数据库与国家死亡登记库中确诊一氧化碳中毒的成人患者,并按年龄、性别、保险类型、收入水平、居住地、吸烟、饮酒、肥胖状态、内外科及精神疾病史和Charlson合并症指数1:1匹配的对照。
  • 随访自2002年至2022年或直至死亡或移民。

研究设计与关键结果

  • 研究类型:基于全国数据库的人群队列研究;共纳入48,600例一氧化碳中毒患者及匹配对照;女性占41.30%,平均年龄48.05岁。
  • 全因死亡:一氧化碳中毒组显著高于对照,aHR 15.67(95%CI 12.58-19.51)。
  • 感染死亡:aHR 6.71(95%CI 1.51-29.72);肿瘤死亡:aHR 5.20(95%CI 3.39-7.99);内分泌死亡:aHR 13.44(95%CI 1.76-102.70);神经死亡:aHR 7.42(95%CI 2.91-18.90);心血管死亡:aHR 8.97(95%CI 5.05-15.93);呼吸死亡:aHR 17.54(95%CI 5.48-56.17);消化死亡:aHR 24.72(95%CI 3.34-182.69)。
  • 外因死亡(包括自杀):一氧化碳中毒组显著高于对照,aHR 50.07(95%CI 30.98-80.90)。

证据类型、等级与局限

  • 证据类型:基于全国登记数据库的人群队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文结论提示,一氧化碳中毒患者全因死亡风险显著高于匹配对照,且两组死因别死亡风险存在差异;原文未据此给出具体推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Carbon monoxide (CO) poisoning can cause brain, heart, and kidney injuries. We aimed to determine the association of risks of all-cause and cause-specific mortality in patients with previous CO poisoning.

DESIGN, SETTING, AND PATIENTS: This population-based cohort study used data from the National Health Insurance Service database and the National Death Registry of Korea. Adult patients diagnosed with CO poisoning and controls between 2002 and 2020 were included. Patients were matched with controls on a 1:1 ratio, considering age, sex, insurance type, income level, residential location, smoking status, alcohol consumption, obesity status, medical and psychiatric illness history, and Charlson Comorbidity Index at the index date. The cohort was monitored from 2002 to 2022 or until death or emigration in terms of all-cause and cause-specific mortality.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: A total of 48,600 patients with CO poisoning and matched controls were included. The cohort included 41.30% females, and the mean age was 48.05 years. Patients with CO poisoning exhibited a substantially elevated risk of all-cause mortality compared with those in the control group, with an adjusted hazard ratio (aHR) of 15.67 (95% CI, 12.58-19.51). The mortality associated with infectious (aHR, 6.71; 95% CI, 1.51-29.72), neoplasm/oncologic (aHR, 5.20; 95% CI, 3.39-7.99), endocrine (aHR, 13.44; 95% CI, 1.76-102.70), neurologic (aHR, 7.42; 95% CI, 2.91-18.90), cardiovascular (aHR, 8.97; 95% CI, 5.05-15.93), respiratory (aHR, 17.54; 95% CI, 5.48-56.17), and gastrointestinal (aHR, 24.72; 95% CI, 3.34-182.69) disorders was significantly greater in the former. Deaths due to external causes, including suicide, were significantly higher in the CO poisoning group (aHR, 50.07; 95% CI, 30.98-80.90).

CONCLUSIONS: Patients with CO poisoning exhibited a heightened risk of all-cause mortality compared with the matched controls. Additionally, the cause-specific mortality risk differed between the groups.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Ahn GJ, Lee S, Heo YW, et al. Mortality Risks and Causes in Previous Carbon Monoxide Poisoning: A Nationwide Population-Based Cohort Study. Crit Care Med. 2024. PMID: 39298511. doi:10.1097/CCM.0000000000006414

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。